Stout served as exclusive financial advisor to Clinique de Maisonneuve (CM) in connection with its stake sale to Impact Healthcare, a company owned by Après-demain (Debiopharm).

Based in Geneva, CM was created in 2013 to support post-acute patients and help them regain their autonomy. Thanks to advanced programs, equipment, and techniques, CM has developed customized rehabilitation care with a wide range of services. CM recently opened a 665-square-meter outpatient rehabilitation center, complementing its first clinic that comprises 44 rooms dedicated to inpatient rehabilitation.

View the full news release.